<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02394743</url>
  </required_header>
  <id_info>
    <org_study_id>PET_eGRF</org_study_id>
    <nct_id>NCT02394743</nct_id>
  </id_info>
  <brief_title>Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University</source>
  <brief_summary>
    <textblock>
      Vascular inflammation is a key factor in both the pathogenesis and outcome of
      atherosclerosis. Renal insufficiency is close correlation with atherosclerosis and
      cardiovascular mortality.

      18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for
      identifying and quantifying vascular inflammation within atherosclerotic plaques.Therefore,
      the purpose of the study is to demonstrate the correlation between eGFR and vascular
      inflammation detected by 18F FDG-PET.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between vascular inflammatory status measured by 18F FDG-PET and eGFR by Modification of Diet in Renal Disease(MDRD) formula</measure>
    <time_frame>at 1 day of taking 18F FDG - PET</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">360</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>eGFR &gt; 90</arm_group_label>
    <description>group whose eGFR is more than 90</description>
  </arm_group>
  <arm_group>
    <arm_group_label>60 &lt; eGFR &lt;90</arm_group_label>
    <description>group whose eGFR is between 60 and 90</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eGFR &lt; 60</arm_group_label>
    <description>group whose eGFR is less than 60</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>18FDG-PET</intervention_name>
    <arm_group_label>eGFR &gt; 90</arm_group_label>
    <arm_group_label>60 &lt; eGFR &lt;90</arm_group_label>
    <arm_group_label>eGFR &lt; 60</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who took 18FDG- PET in Korea Guro University
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. absence of prior cancer diagnosis or remission from cancer at the time of PET imaging
             and throughout the follow-up period;

          2. &gt;=30 years of age;

          3. no prior history of cardiovascular disease ; and

          4. absence of acute or chronic inflammatory or autoimmune disease (based on documented
             medical history) or use of chronic anti-inflammatory therapy.

        Exclusion Criteria:

          1. age &lt;35 years

          2. presence of chronic inflammatory disease

          3. use of anti-inflammatory medications

          4. presence of active malignant cancer (defined as any radiological or pathological
             evidence of malignant cancer disease or undergoing chemotherapy or radiation therapy
             within 1 year before initial PET/CT and throughout the inter-scan duration).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Internal Medicine, Korea University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <state>VD</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2015</study_first_submitted>
  <study_first_submitted_qc>March 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2015</study_first_posted>
  <last_update_submitted>September 6, 2016</last_update_submitted>
  <last_update_submitted_qc>September 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University</investigator_affiliation>
    <investigator_full_name>Kyung Mook Choi</investigator_full_name>
    <investigator_title>Medical professor</investigator_title>
  </responsible_party>
  <keyword>Glomerular Filtration Rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

